Breakfast of champions: MIT hosts top young scientists
At an MIT-led event at AJAS/AAAS, researchers connect with MIT faculty, Nobel laureates, and industry leaders to share their work, gain mentorship, and explore future careers in science.
At an MIT-led event at AJAS/AAAS, researchers connect with MIT faculty, Nobel laureates, and industry leaders to share their work, gain mentorship, and explore future careers in science.
Stefani Spranger is working to discover why some cancers don’t respond to immunotherapy, in hopes of making them more vulnerable to it.
Four professors and an additional alumnus honored with nation’s highest awards for scientists and engineers; Moderna, with deep MIT roots, also recognized.
Five MIT faculty and staff, along with 19 additional alumni, are honored for electrical engineering and computer science advances.
Ten objects on display in the Koch Institute Public Galleries offer uncommon insights into the people and progress of MIT's cancer research community.
The MIT Health and Life Sciences Collaborative will bring together researchers from across the Institute to deliver health care solutions at scale.
MIT chemical engineers designed an environmentally friendly alternative to the microbeads used in some health and beauty products.
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
MIT graduate student earns top honors in Graduate and People’s Choice categories for her work on nutrient-stabilizing materials.
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.
The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.
Professors Matthew Vander Heiden and Fan Wang, along with five MIT alumni, are honored for their outstanding professional achievement and commitment to service.
Labs that can’t afford expensive super-resolution microscopes could use a new expansion technique to image nanoscale structures inside cells.
Study reveals the drug, 5-fluorouracil, acts differently in different types of cancer — a finding that could help researchers design better drug combinations.
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.